Clinical Trial Update: Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing tegoprazan-amoxicillin dual therapy to bismuth quadruple therapy for Helicobacter pylori infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Bismuth quadruple therapy
• Tegoprazan-Amoxicillin Dual Therapy

Snippet

Sponsor: Zhang Xiaofeng,MD | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED